News and Events

Nov 20, 2020

NIH has a long history of ground-breaking research developments that have led to life-changing vaccines and your organization could be a part of the next important vaccine. The NIH Intramural Research Program (IRP) has published an interesting and informative timeline of the various IRP’s contributions to vaccine development that highlight NIH’s involvement in producing vaccines such as smallpox, rubella, hepatitis A, whooping cough, and human papillomavirus (HPV), among many others.

Nov 12, 2020

This year marks the 40th anniversary of the Bayh-Dole Act. This historic piece of legislation was passed in order to allow inventors to retain ownership of the IP of inventions made under contract with the federal government. This act resulted in a large increase in public-private collaborations and led to countless scientific advances. According to the Bayh-Dole 40 website, the BDA has increased U.S. economic output by $1.7 trillion and supported 5.9 million jobs.

Oct 12, 2020

The current methods for early detection and surveillance of liver cancer, such as hepatocellular carcinoma (HCC), are inadequate. Due to this, scientists at NCI’s Laboratory of Human Carcinogenesis have developed a blood test to check for a patient’s previous exposure to certain viruses that would make them more at risk to develop HCC. Liver cancer is the leading cause of cancer deaths worldwide and early detection is key to improving mortality, so this new technology could be very impactful and will have a large market.

Oct 5, 2020

Artificial intelligence and computer aided diagnosis (CAD) technologies are on the cutting edge of medical imaging, detection, and diagnosis. Smart technology is becoming increasingly popular as it can help to reduce false positives as a consequence of fatigue and bias from radiologists. The NIH Clinical Center has developed a CAD and eye-tracking system for radiology reading.

Sep 9, 2020

It is estimated that one American develops Alzheimer’s Disease every 65 seconds, with that rate projected to accelerate. Current approaches to treating Alzheimer’s focus on helping people maintain mental function, manage behavioral symptoms, and slow down the symptoms of the disease, but there is nothing on the market that could prevent or reverse neuronal degeneration. This technology offers a way to do just that.

Sep 2, 2020

As the largest basic science research institute in the world, it can be daunting to find out how to access the opportunities for businesses available at NIH. On September 22, 2020 BioNJ is hosting a webinar featuring the National Cancer Institute’s Michael Salgaller to discuss how to collaborate with or license from the NIH. By attending this free one-hour webinar you will hear how to access the many services and resources available through the NIH.

Aug 25, 2020

Interested in expanding your knowledge base? Registration for the Foundation for Advanced Education in the Sciences (FAES) Fall 2020 courses at NIH are now open. The Fall semester is offering courses in Biology, Chemistry, Bioinformatics, Immunology, Languages and General Studies, Microbiology, Medicine, Public Health, Statistics, and Technology Transfer. There are many courses being offered this semester, including Introduction to Technology Transfer: Issues and Processes. All courses this semester will be online, so it can easily be fit into your schedule.

Aug 19, 2020

The 2020 Technology Showcase will be held virtually on September 9, 2020. The Showcase started four years ago as a way to highlight technologies developed at the National Cancer Institute (NCI) and the Frederick National Laboratory for Cancer Research (FNLCR) to encourage the translation of NCI discoveries into solutions to benefit patients.

Aug 12, 2020

The Federal Laboratory Consortium (FLC) for Technology Transfer is hosting their annual meeting virtually from August 31 to September 3, 2020. It is the largest federal technology transfer meeting of the year. You will be able to join other FLC colleagues for professional development sessions, awards recognition, and networking.

Dec 4, 2019

Scientists at the National Institutes of Health found that women who use permanent hair dye and chemical hair straighteners have a higher risk of developing breast cancer than women who don’t use these products. The study published online Dec. 4 in the International Journal of Cancer and suggests that breast cancer risk increased with more frequent use of these chemical hair products.